Country

Clinical trials in Georgia

Active obesity and GLP-1 studies with at least one location in Georgia.

2active studies

1recruiting now

3countries represented

9largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

Obese With Comorbidities, Obese Patients (BMI ≥ 30 kg/m²)Condition

APHD-012, APHD-002Treatment

Georgia6 locations

Aphaia Pharma US LLCSponsor

Updated 2025-09-16 · NCT07008456See eligibility →

Active, not recruitingPhase 2

ObeseCondition

APHD-012, APHD-012PTreatment

Georgia, Germany9 locations

Aphaia Pharma US LLCSponsor

Updated 2024-10-16 · NCT05385978See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.